RecruitingNCT05340023

Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension

Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension : PROTEO-CTEPH Study.

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Enrollment

120 participants

Start Date

Nov 9, 2022

Study Type

OBSERVATIONAL

Conditions

Chronic Thromboembolic Pulmonary Hypertension

Summary

Chronic ThromboEmbolic Pulmonary Hypertension (CTEPH) is a rare but severe complication of pulmonary embolism (PE). CTEPH is evoked in patients with persistent dyspnea. According to international guidelines, symptomatic patients with perfusion defects on lung scan and Pulmonary Hypertension (PH)-likely transthoracic echo (TTE) must be evaluated in Pulmonary Hypertension (PH)-centers with right heart catheterism, to confirm or rule out the presence of precapillary Pulmonary Hypertension (PH), and precise the group of Pulmonary Hypertension (PH).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking for patterns in proteins in the blood that could help diagnose chronic thromboembolic pulmonary hypertension (CTEPH) — a serious condition where old blood clots block blood flow through the lungs, raising blood pressure in the pulmonary arteries. **You may be eligible if...** - You are suspected of having CTEPH based on your lung scan and echocardiogram results - You are scheduled for a right heart catheterization (a procedure to measure pressures inside the heart and lungs) - You are affiliated with a social security plan (French requirement) **You may NOT be eligible if...** - Your lung perfusion scan is normal - You are under legal guardianship Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALblood sample

to realize proteomic analysis.

Locations(1)

CHU de SAINT-ETIENNE

Saint-Etienne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05340023

Related Trials

129Xe MRI Cardiopulmonary

NCT060386301 location

Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension

NCT072727981 location